
Hair & skin, the proven list
The treatments with actual trials behind them, and one cosmetic peptide I like.
GHK-Cu is a peptide that is sold over the counter.
Also known as Copper peptide, Copper tripeptide-1, Glycyl-L-histidyl-L-lysine copper
GHK-Cu is a naturally occurring tripeptide bound to copper. It is widely used in cosmetic serums for skin firmness and hair products, while injectable versions sold online are a separate, unapproved use.
In 1 example journal

Sold without a prescription. Supplements are not reviewed by the FDA before sale, so third-party testing matters. Topical GHK-Cu is legally sold as a cosmetic ingredient. Injectable GHK-Cu is not approved; its nomination was withdrawn in April 2026, while non-injectable GHK-Cu is back in FDA's 503A Category 1 with an advisory committee review planned before the end of February 2027.
As of September 23, 2026.
Key takeaways
GHK is a tiny three-amino-acid peptide found in human blood that binds copper. In lab and animal studies, GHK-Cu supports wound repair, collagen production and new blood vessel growth, and changes the activity of many genes.
In skin care, the idea is that applying it helps skin look firmer. Small cosmetic studies report modest changes, but the larger claims come from lab and animal work.



GHK-Cu is frequently paired with microneedling in online routines, but FDA-authorized microneedling devices are not cleared to deliver cosmetic serums, topical medications, vitamins, drugs or blood products into the skin. FDA says the risks of combining microneedling with products it has not evaluated are not known. FDA: Microneedling devices
A normal cosmetic serum is formulated for intact skin and should not be assumed to be sterile or suitable for freshly punctured skin. The available GHK-Cu study often cited in this area was a small study after laser resurfacing, not a trial of at-home microneedling with GHK-Cu. Topical copper tripeptide complex after CO2 laser resurfacing (small study)
If you are considering professional microneedling, ask the treating clinician which aftercare products they use, why they use them, whether the product is intended for use on disrupted skin and what complications should prompt follow-up.
Small cosmetic studies suggest modest skin benefits from topical use; claims for injectable or systemic benefits rest on lab and animal data.
Topical GHK-Cu is considered a low-risk cosmetic ingredient with modest evidence. Regulators are cautious about injectable forms.
FDA listed injectable GHK-Cu as possibly posing a risk of immune reactions from aggregation and impurities, noting limited data in humans. The nomination was later withdrawn.
FDA: Bulk drug substances that may present significant safety risks (Category 2)In April 2026 FDA removed GHK-Cu from its compounding category lists after nominations were withdrawn; removal does not place it on the list pharmacies may compound from. Non-injectable GHK-Cu was later returned to Category 1 for review.
FDA: 503A bulk drug substance categories list (May 14, 2026)A 2018 review of GHK-Cu describes wound-healing and skin effects mostly from lab, animal and small cosmetic studies.
Regenerative and protective actions of GHK-Cu (review, 2018)A 2026 review of peptides in sports medicine found no clinical data supporting GHK-Cu for musculoskeletal conditions.
Injectable peptide therapy: a primer for orthopaedic and sports medicine physicians (Am J Sports Med 2026)Summaries of published guidelines, drug labels, regulators and reviews, each attributed to its source. DiscoverMedica does not employ clinicians.
Only a licensed clinician who knows your history can decide whether it is right for you.
These save with the compound when you add it to My Journal, so they’re on the printout for your visit.

Topical GHK-Cu serums are sold as cosmetics without a prescription.
Some telehealth services sell a GHK-Cu product as part of a hair program, after an online intake.
Injectable versions are not available through a lawful route while FDA reviews the ingredient.
From each provider’s own site, checked September 23, 2026. Programs change, so confirm the details before you sign up.
6 providers list GHK-Cu on DiscoverMedica, lowest listed price first.
† Prices as listed by the provider when we checked; they change.
Topical use is generally well tolerated in cosmetic studies. Patch test first, especially if you have sensitive skin.
There is no good human evidence that it does. Products sold for hair are labeled as cosmetics, not hair-loss treatments.
The combination is promoted online, but FDA-authorized microneedling devices are not cleared to deliver cosmetics or drugs into the skin. A serum made for intact skin should not be assumed to be sterile or suitable for freshly punctured skin.
It is not approved, and FDA has raised concerns about immune reactions and impurities. It is not lawfully available for personal use while FDA reviews it.
Only topical cosmetic products. At least one telehealth brand sells a topical hair foam. Injectable GHK-Cu has no lawful telehealth route today.
This is not a complete list of risks. Talk to a licensed clinician or pharmacist about your own situation. If you have a severe reaction, call 911. You can report side effects to the FDA through MedWatch at 1-800-FDA-1088.
Guide reviewed September 23, 2026.
Educational information only, not medical advice. It does not replace a conversation with a licensed clinician.

The treatments with actual trials behind them, and one cosmetic peptide I like.
A lab-made peptide popular for injury recovery. Mostly animal data, and not an approved drug.
A synthetic fragment of thymosin beta-4 marketed for recovery. Animal data only; not approved.
A protein supplement made from animal collagen, popular for skin, joints and recovery.
A gentle form of magnesium that people take for sleep and relaxation.